nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadopentetate dimeglumine—PGD—Dacarbazine—melanoma	0.886	1	CbGbCtD
Gadopentetate dimeglumine—Gadobenate Dimeglumine—ALB—melanoma	0.00123	1	CrCbGaD
Gadopentetate dimeglumine—Anaphylactic shock—Vemurafenib—melanoma	0.000474	0.00436	CcSEcCtD
Gadopentetate dimeglumine—Nervous system disorder—Vemurafenib—melanoma	0.000465	0.00427	CcSEcCtD
Gadopentetate dimeglumine—PGD—NRF2 pathway—SLC39A12—melanoma	0.000464	0.135	CbGpPWpGaD
Gadopentetate dimeglumine—Skin disorder—Vemurafenib—melanoma	0.00046	0.00423	CcSEcCtD
Gadopentetate dimeglumine—Blood pressure increased—Docetaxel—melanoma	0.000452	0.00415	CcSEcCtD
Gadopentetate dimeglumine—Injection site reaction—Docetaxel—melanoma	0.000449	0.00413	CcSEcCtD
Gadopentetate dimeglumine—Acute coronary syndrome—Bleomycin—melanoma	0.000444	0.00408	CcSEcCtD
Gadopentetate dimeglumine—Toxic epidermal necrolysis—Temozolomide—melanoma	0.000444	0.00408	CcSEcCtD
Gadopentetate dimeglumine—Hypotension—Vemurafenib—melanoma	0.000443	0.00407	CcSEcCtD
Gadopentetate dimeglumine—Myocardial infarction—Bleomycin—melanoma	0.000441	0.00406	CcSEcCtD
Gadopentetate dimeglumine—Musculoskeletal discomfort—Vemurafenib—melanoma	0.000432	0.00397	CcSEcCtD
Gadopentetate dimeglumine—Decreased appetite—Vemurafenib—melanoma	0.000412	0.00379	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal disorder—Vemurafenib—melanoma	0.000409	0.00376	CcSEcCtD
Gadopentetate dimeglumine—Fatigue—Vemurafenib—melanoma	0.000409	0.00376	CcSEcCtD
Gadopentetate dimeglumine—Constipation—Vemurafenib—melanoma	0.000405	0.00373	CcSEcCtD
Gadopentetate dimeglumine—Lightheadedness—Docetaxel—melanoma	0.000404	0.00372	CcSEcCtD
Gadopentetate dimeglumine—Pulmonary oedema—Docetaxel—melanoma	0.000402	0.0037	CcSEcCtD
Gadopentetate dimeglumine—Pollakiuria—Temozolomide—melanoma	0.000393	0.00362	CcSEcCtD
Gadopentetate dimeglumine—Renal failure—Carmustine—melanoma	0.000386	0.00355	CcSEcCtD
Gadopentetate dimeglumine—Phlebitis—Docetaxel—melanoma	0.00038	0.0035	CcSEcCtD
Gadopentetate dimeglumine—Thrombophlebitis—Docetaxel—melanoma	0.000379	0.00348	CcSEcCtD
Gadopentetate dimeglumine—Flushing—Bleomycin—melanoma	0.000375	0.00345	CcSEcCtD
Gadopentetate dimeglumine—Body temperature increased—Vemurafenib—melanoma	0.000375	0.00345	CcSEcCtD
Gadopentetate dimeglumine—Deafness—Docetaxel—melanoma	0.000366	0.00337	CcSEcCtD
Gadopentetate dimeglumine—Chills—Bleomycin—melanoma	0.000363	0.00334	CcSEcCtD
Gadopentetate dimeglumine—Hepatobiliary disease—Temozolomide—melanoma	0.000359	0.0033	CcSEcCtD
Gadopentetate dimeglumine—Erythema multiforme—Dactinomycin—melanoma	0.000356	0.00328	CcSEcCtD
Gadopentetate dimeglumine—Erythema—Bleomycin—melanoma	0.000352	0.00324	CcSEcCtD
Gadopentetate dimeglumine—Flushing—Dactinomycin—melanoma	0.00035	0.00322	CcSEcCtD
Gadopentetate dimeglumine—Hypersensitivity—Vemurafenib—melanoma	0.000349	0.00321	CcSEcCtD
Gadopentetate dimeglumine—Oedema peripheral—Carmustine—melanoma	0.000348	0.0032	CcSEcCtD
Gadopentetate dimeglumine—Connective tissue disorder—Carmustine—melanoma	0.000347	0.00319	CcSEcCtD
Gadopentetate dimeglumine—Visual disturbance—Docetaxel—melanoma	0.000346	0.00318	CcSEcCtD
Gadopentetate dimeglumine—Renal impairment—Docetaxel—melanoma	0.000344	0.00317	CcSEcCtD
Gadopentetate dimeglumine—Asthenia—Vemurafenib—melanoma	0.00034	0.00313	CcSEcCtD
Gadopentetate dimeglumine—Visual impairment—Carmustine—melanoma	0.00034	0.00313	CcSEcCtD
Gadopentetate dimeglumine—Chills—Dactinomycin—melanoma	0.000338	0.00311	CcSEcCtD
Gadopentetate dimeglumine—Urinary tract disorder—Temozolomide—melanoma	0.000337	0.0031	CcSEcCtD
Gadopentetate dimeglumine—Oedema peripheral—Temozolomide—melanoma	0.000336	0.00309	CcSEcCtD
Gadopentetate dimeglumine—Pruritus—Vemurafenib—melanoma	0.000335	0.00308	CcSEcCtD
Gadopentetate dimeglumine—Connective tissue disorder—Temozolomide—melanoma	0.000335	0.00308	CcSEcCtD
Gadopentetate dimeglumine—Urethral disorder—Temozolomide—melanoma	0.000334	0.00307	CcSEcCtD
Gadopentetate dimeglumine—Eye disorder—Carmustine—melanoma	0.00033	0.00303	CcSEcCtD
Gadopentetate dimeglumine—Visual impairment—Temozolomide—melanoma	0.000329	0.00302	CcSEcCtD
Gadopentetate dimeglumine—Erythema—Dactinomycin—melanoma	0.000328	0.00302	CcSEcCtD
Gadopentetate dimeglumine—Pain in extremity—Docetaxel—melanoma	0.000328	0.00301	CcSEcCtD
Gadopentetate dimeglumine—Flushing—Carmustine—melanoma	0.000327	0.00301	CcSEcCtD
Gadopentetate dimeglumine—Diarrhoea—Vemurafenib—melanoma	0.000324	0.00298	CcSEcCtD
Gadopentetate dimeglumine—Migraine—Docetaxel—melanoma	0.000323	0.00297	CcSEcCtD
Gadopentetate dimeglumine—Erythema multiforme—Temozolomide—melanoma	0.000322	0.00296	CcSEcCtD
Gadopentetate dimeglumine—Eye disorder—Temozolomide—melanoma	0.000319	0.00293	CcSEcCtD
Gadopentetate dimeglumine—Tinnitus—Temozolomide—melanoma	0.000318	0.00292	CcSEcCtD
Gadopentetate dimeglumine—Malaise—Bleomycin—melanoma	0.000317	0.00292	CcSEcCtD
Gadopentetate dimeglumine—Flushing—Temozolomide—melanoma	0.000316	0.00291	CcSEcCtD
Gadopentetate dimeglumine—Cardiac disorder—Temozolomide—melanoma	0.000316	0.00291	CcSEcCtD
Gadopentetate dimeglumine—Arrhythmia—Carmustine—melanoma	0.000315	0.0029	CcSEcCtD
Gadopentetate dimeglumine—Dizziness—Vemurafenib—melanoma	0.000313	0.00288	CcSEcCtD
Gadopentetate dimeglumine—Angiopathy—Temozolomide—melanoma	0.000309	0.00285	CcSEcCtD
Gadopentetate dimeglumine—Mental disorder—Carmustine—melanoma	0.000309	0.00284	CcSEcCtD
Gadopentetate dimeglumine—Immune system disorder—Temozolomide—melanoma	0.000308	0.00283	CcSEcCtD
Gadopentetate dimeglumine—Mediastinal disorder—Temozolomide—melanoma	0.000307	0.00283	CcSEcCtD
Gadopentetate dimeglumine—Erythema—Carmustine—melanoma	0.000307	0.00282	CcSEcCtD
Gadopentetate dimeglumine—Cough—Bleomycin—melanoma	0.000307	0.00282	CcSEcCtD
Gadopentetate dimeglumine—Chills—Temozolomide—melanoma	0.000306	0.00281	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Vemurafenib—melanoma	0.000301	0.00277	CcSEcCtD
Gadopentetate dimeglumine—Chest pain—Bleomycin—melanoma	0.0003	0.00276	CcSEcCtD
Gadopentetate dimeglumine—Abdominal pain upper—Docetaxel—melanoma	0.000299	0.00275	CcSEcCtD
Gadopentetate dimeglumine—Rash—Vemurafenib—melanoma	0.000299	0.00275	CcSEcCtD
Gadopentetate dimeglumine—Mental disorder—Temozolomide—melanoma	0.000299	0.00275	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Vemurafenib—melanoma	0.000299	0.00275	CcSEcCtD
Gadopentetate dimeglumine—Back pain—Carmustine—melanoma	0.000297	0.00273	CcSEcCtD
Gadopentetate dimeglumine—Headache—Vemurafenib—melanoma	0.000297	0.00273	CcSEcCtD
Gadopentetate dimeglumine—Erythema—Temozolomide—melanoma	0.000297	0.00273	CcSEcCtD
Gadopentetate dimeglumine—Malaise—Dactinomycin—melanoma	0.000296	0.00272	CcSEcCtD
Gadopentetate dimeglumine—Toxic epidermal necrolysis—Docetaxel—melanoma	0.000295	0.00271	CcSEcCtD
Gadopentetate dimeglumine—Nasopharyngitis—Docetaxel—melanoma	0.000293	0.0027	CcSEcCtD
Gadopentetate dimeglumine—Dysgeusia—Temozolomide—melanoma	0.000291	0.00267	CcSEcCtD
Gadopentetate dimeglumine—Confusional state—Bleomycin—melanoma	0.00029	0.00266	CcSEcCtD
Gadopentetate dimeglumine—Tremor—Carmustine—melanoma	0.000288	0.00265	CcSEcCtD
Gadopentetate dimeglumine—Anaphylactic shock—Bleomycin—melanoma	0.000287	0.00264	CcSEcCtD
Gadopentetate dimeglumine—Back pain—Temozolomide—melanoma	0.000287	0.00264	CcSEcCtD
Gadopentetate dimeglumine—Agitation—Carmustine—melanoma	0.000282	0.0026	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Vemurafenib—melanoma	0.000282	0.00259	CcSEcCtD
Gadopentetate dimeglumine—Bronchospasm—Docetaxel—melanoma	0.000279	0.00256	CcSEcCtD
Gadopentetate dimeglumine—Tremor—Temozolomide—melanoma	0.000278	0.00256	CcSEcCtD
Gadopentetate dimeglumine—Angina pectoris—Docetaxel—melanoma	0.000276	0.00254	CcSEcCtD
Gadopentetate dimeglumine—Anorexia—Bleomycin—melanoma	0.000274	0.00252	CcSEcCtD
Gadopentetate dimeglumine—Agitation—Temozolomide—melanoma	0.000273	0.00251	CcSEcCtD
Gadopentetate dimeglumine—Angioedema—Temozolomide—melanoma	0.000271	0.00249	CcSEcCtD
Gadopentetate dimeglumine—Hypotension—Bleomycin—melanoma	0.000268	0.00247	CcSEcCtD
Gadopentetate dimeglumine—Malaise—Temozolomide—melanoma	0.000268	0.00246	CcSEcCtD
Gadopentetate dimeglumine—Convulsion—Carmustine—melanoma	0.000266	0.00245	CcSEcCtD
Gadopentetate dimeglumine—Hypertension—Carmustine—melanoma	0.000265	0.00244	CcSEcCtD
Gadopentetate dimeglumine—Musculoskeletal discomfort—Bleomycin—melanoma	0.000262	0.00241	CcSEcCtD
Gadopentetate dimeglumine—Chest pain—Carmustine—melanoma	0.000261	0.0024	CcSEcCtD
Gadopentetate dimeglumine—Anxiety—Carmustine—melanoma	0.000261	0.0024	CcSEcCtD
Gadopentetate dimeglumine—Cough—Temozolomide—melanoma	0.000259	0.00238	CcSEcCtD
Gadopentetate dimeglumine—Paraesthesia—Bleomycin—melanoma	0.000258	0.00237	CcSEcCtD
Gadopentetate dimeglumine—Convulsion—Temozolomide—melanoma	0.000257	0.00237	CcSEcCtD
Gadopentetate dimeglumine—Hypertension—Temozolomide—melanoma	0.000256	0.00236	CcSEcCtD
Gadopentetate dimeglumine—Dyspnoea—Bleomycin—melanoma	0.000256	0.00235	CcSEcCtD
Gadopentetate dimeglumine—Anorexia—Dactinomycin—melanoma	0.000255	0.00235	CcSEcCtD
Gadopentetate dimeglumine—Confusional state—Carmustine—melanoma	0.000253	0.00232	CcSEcCtD
Gadopentetate dimeglumine—Arthralgia—Temozolomide—melanoma	0.000253	0.00232	CcSEcCtD
Gadopentetate dimeglumine—Anxiety—Temozolomide—melanoma	0.000252	0.00232	CcSEcCtD
Gadopentetate dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.000251	0.00231	CcSEcCtD
Gadopentetate dimeglumine—Decreased appetite—Bleomycin—melanoma	0.00025	0.0023	CcSEcCtD
Gadopentetate dimeglumine—Acute coronary syndrome—Docetaxel—melanoma	0.000249	0.00229	CcSEcCtD
Gadopentetate dimeglumine—Renal failure—Docetaxel—melanoma	0.000248	0.00228	CcSEcCtD
Gadopentetate dimeglumine—Myocardial infarction—Docetaxel—melanoma	0.000248	0.00228	CcSEcCtD
Gadopentetate dimeglumine—Dry mouth—Temozolomide—melanoma	0.000247	0.00227	CcSEcCtD
Gadopentetate dimeglumine—Pain—Bleomycin—melanoma	0.000246	0.00226	CcSEcCtD
Gadopentetate dimeglumine—Conjunctivitis—Docetaxel—melanoma	0.000245	0.00226	CcSEcCtD
Gadopentetate dimeglumine—Tachycardia—Carmustine—melanoma	0.000245	0.00225	CcSEcCtD
Gadopentetate dimeglumine—Confusional state—Temozolomide—melanoma	0.000244	0.00225	CcSEcCtD
Gadopentetate dimeglumine—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000244	0.00224	CcSEcCtD
Gadopentetate dimeglumine—Anaphylactic shock—Temozolomide—melanoma	0.000242	0.00223	CcSEcCtD
Gadopentetate dimeglumine—Anorexia—Carmustine—melanoma	0.000239	0.0022	CcSEcCtD
Gadopentetate dimeglumine—Hepatobiliary disease—Docetaxel—melanoma	0.000239	0.0022	CcSEcCtD
Gadopentetate dimeglumine—Nervous system disorder—Temozolomide—melanoma	0.000238	0.00218	CcSEcCtD
Gadopentetate dimeglumine—Feeling abnormal—Bleomycin—melanoma	0.000237	0.00218	CcSEcCtD
Gadopentetate dimeglumine—Skin disorder—Temozolomide—melanoma	0.000235	0.00216	CcSEcCtD
Gadopentetate dimeglumine—Hypotension—Carmustine—melanoma	0.000234	0.00215	CcSEcCtD
Gadopentetate dimeglumine—Hyperhidrosis—Temozolomide—melanoma	0.000234	0.00215	CcSEcCtD
Gadopentetate dimeglumine—Decreased appetite—Dactinomycin—melanoma	0.000233	0.00214	CcSEcCtD
Gadopentetate dimeglumine—Fatigue—Dactinomycin—melanoma	0.000231	0.00212	CcSEcCtD
Gadopentetate dimeglumine—Anorexia—Temozolomide—melanoma	0.000231	0.00212	CcSEcCtD
Gadopentetate dimeglumine—Pain—Dactinomycin—melanoma	0.000229	0.00211	CcSEcCtD
Gadopentetate dimeglumine—Musculoskeletal discomfort—Carmustine—melanoma	0.000228	0.0021	CcSEcCtD
Gadopentetate dimeglumine—Urticaria—Bleomycin—melanoma	0.000228	0.0021	CcSEcCtD
Gadopentetate dimeglumine—Rhinitis—Docetaxel—melanoma	0.000227	0.00209	CcSEcCtD
Gadopentetate dimeglumine—Body temperature increased—Bleomycin—melanoma	0.000227	0.00209	CcSEcCtD
Gadopentetate dimeglumine—PGD—NRF2 pathway—EPHA2—melanoma	0.000227	0.0658	CbGpPWpGaD
Gadopentetate dimeglumine—Paraesthesia—Carmustine—melanoma	0.000225	0.00207	CcSEcCtD
Gadopentetate dimeglumine—Urinary tract disorder—Docetaxel—melanoma	0.000224	0.00206	CcSEcCtD
Gadopentetate dimeglumine—Dyspnoea—Carmustine—melanoma	0.000223	0.00206	CcSEcCtD
Gadopentetate dimeglumine—Oedema peripheral—Docetaxel—melanoma	0.000223	0.00205	CcSEcCtD
Gadopentetate dimeglumine—Somnolence—Carmustine—melanoma	0.000223	0.00205	CcSEcCtD
Gadopentetate dimeglumine—Connective tissue disorder—Docetaxel—melanoma	0.000223	0.00205	CcSEcCtD
Gadopentetate dimeglumine—Urethral disorder—Docetaxel—melanoma	0.000222	0.00204	CcSEcCtD
Gadopentetate dimeglumine—Feeling abnormal—Dactinomycin—melanoma	0.000221	0.00203	CcSEcCtD
Gadopentetate dimeglumine—Musculoskeletal discomfort—Temozolomide—melanoma	0.000221	0.00203	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal pain—Dactinomycin—melanoma	0.000219	0.00201	CcSEcCtD
Gadopentetate dimeglumine—Visual impairment—Docetaxel—melanoma	0.000218	0.00201	CcSEcCtD
Gadopentetate dimeglumine—Decreased appetite—Carmustine—melanoma	0.000218	0.002	CcSEcCtD
Gadopentetate dimeglumine—Paraesthesia—Temozolomide—melanoma	0.000217	0.002	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal disorder—Carmustine—melanoma	0.000216	0.00199	CcSEcCtD
Gadopentetate dimeglumine—Dyspnoea—Temozolomide—melanoma	0.000216	0.00199	CcSEcCtD
Gadopentetate dimeglumine—Somnolence—Temozolomide—melanoma	0.000215	0.00198	CcSEcCtD
Gadopentetate dimeglumine—Erythema multiforme—Docetaxel—melanoma	0.000214	0.00197	CcSEcCtD
Gadopentetate dimeglumine—Pain—Carmustine—melanoma	0.000214	0.00197	CcSEcCtD
Gadopentetate dimeglumine—Constipation—Carmustine—melanoma	0.000214	0.00197	CcSEcCtD
Gadopentetate dimeglumine—PGD—NRF2 pathway—SLC6A11—melanoma	0.000213	0.0619	CbGpPWpGaD
Gadopentetate dimeglumine—Eye disorder—Docetaxel—melanoma	0.000212	0.00195	CcSEcCtD
Gadopentetate dimeglumine—Abdominal pain—Dactinomycin—melanoma	0.000212	0.00195	CcSEcCtD
Gadopentetate dimeglumine—Body temperature increased—Dactinomycin—melanoma	0.000212	0.00195	CcSEcCtD
Gadopentetate dimeglumine—Hypersensitivity—Bleomycin—melanoma	0.000212	0.00195	CcSEcCtD
Gadopentetate dimeglumine—Decreased appetite—Temozolomide—melanoma	0.000211	0.00194	CcSEcCtD
Gadopentetate dimeglumine—Flushing—Docetaxel—melanoma	0.00021	0.00194	CcSEcCtD
Gadopentetate dimeglumine—Cardiac disorder—Docetaxel—melanoma	0.00021	0.00194	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal disorder—Temozolomide—melanoma	0.000209	0.00192	CcSEcCtD
Gadopentetate dimeglumine—Fatigue—Temozolomide—melanoma	0.000209	0.00192	CcSEcCtD
Gadopentetate dimeglumine—Constipation—Temozolomide—melanoma	0.000207	0.00191	CcSEcCtD
Gadopentetate dimeglumine—Pain—Temozolomide—melanoma	0.000207	0.00191	CcSEcCtD
Gadopentetate dimeglumine—Feeling abnormal—Carmustine—melanoma	0.000207	0.0019	CcSEcCtD
Gadopentetate dimeglumine—Asthenia—Bleomycin—melanoma	0.000206	0.00189	CcSEcCtD
Gadopentetate dimeglumine—Angiopathy—Docetaxel—melanoma	0.000206	0.00189	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal pain—Carmustine—melanoma	0.000205	0.00189	CcSEcCtD
Gadopentetate dimeglumine—Immune system disorder—Docetaxel—melanoma	0.000205	0.00188	CcSEcCtD
Gadopentetate dimeglumine—Mediastinal disorder—Docetaxel—melanoma	0.000204	0.00188	CcSEcCtD
Gadopentetate dimeglumine—Chills—Docetaxel—melanoma	0.000203	0.00187	CcSEcCtD
Gadopentetate dimeglumine—Pruritus—Bleomycin—melanoma	0.000203	0.00187	CcSEcCtD
Gadopentetate dimeglumine—Arrhythmia—Docetaxel—melanoma	0.000203	0.00186	CcSEcCtD
Gadopentetate dimeglumine—Feeling abnormal—Temozolomide—melanoma	0.0002	0.00184	CcSEcCtD
Gadopentetate dimeglumine—Mental disorder—Docetaxel—melanoma	0.000199	0.00183	CcSEcCtD
Gadopentetate dimeglumine—Abdominal pain—Carmustine—melanoma	0.000198	0.00182	CcSEcCtD
Gadopentetate dimeglumine—Body temperature increased—Carmustine—melanoma	0.000198	0.00182	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal pain—Temozolomide—melanoma	0.000198	0.00182	CcSEcCtD
Gadopentetate dimeglumine—Erythema—Docetaxel—melanoma	0.000197	0.00182	CcSEcCtD
Gadopentetate dimeglumine—Hypersensitivity—Dactinomycin—melanoma	0.000197	0.00181	CcSEcCtD
Gadopentetate dimeglumine—Dysgeusia—Docetaxel—melanoma	0.000193	0.00178	CcSEcCtD
Gadopentetate dimeglumine—Urticaria—Temozolomide—melanoma	0.000192	0.00177	CcSEcCtD
Gadopentetate dimeglumine—Asthenia—Dactinomycin—melanoma	0.000192	0.00177	CcSEcCtD
Gadopentetate dimeglumine—Body temperature increased—Temozolomide—melanoma	0.000191	0.00176	CcSEcCtD
Gadopentetate dimeglumine—Abdominal pain—Temozolomide—melanoma	0.000191	0.00176	CcSEcCtD
Gadopentetate dimeglumine—Back pain—Docetaxel—melanoma	0.000191	0.00176	CcSEcCtD
Gadopentetate dimeglumine—PGD—Carbohydrate metabolism—HS3ST5—melanoma	0.000189	0.0549	CbGpPWpGaD
Gadopentetate dimeglumine—Hypersensitivity—Carmustine—melanoma	0.000185	0.0017	CcSEcCtD
Gadopentetate dimeglumine—Diarrhoea—Dactinomycin—melanoma	0.000183	0.00169	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Bleomycin—melanoma	0.000183	0.00168	CcSEcCtD
Gadopentetate dimeglumine—Rash—Bleomycin—melanoma	0.000181	0.00167	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Bleomycin—melanoma	0.000181	0.00166	CcSEcCtD
Gadopentetate dimeglumine—Asthenia—Carmustine—melanoma	0.00018	0.00165	CcSEcCtD
Gadopentetate dimeglumine—Hypersensitivity—Temozolomide—melanoma	0.000178	0.00164	CcSEcCtD
Gadopentetate dimeglumine—Syncope—Docetaxel—melanoma	0.000177	0.00163	CcSEcCtD
Gadopentetate dimeglumine—Asthenia—Temozolomide—melanoma	0.000174	0.0016	CcSEcCtD
Gadopentetate dimeglumine—Loss of consciousness—Docetaxel—melanoma	0.000173	0.0016	CcSEcCtD
Gadopentetate dimeglumine—Cough—Docetaxel—melanoma	0.000172	0.00158	CcSEcCtD
Gadopentetate dimeglumine—Diarrhoea—Carmustine—melanoma	0.000171	0.00158	CcSEcCtD
Gadopentetate dimeglumine—Pruritus—Temozolomide—melanoma	0.000171	0.00158	CcSEcCtD
Gadopentetate dimeglumine—Convulsion—Docetaxel—melanoma	0.000171	0.00157	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Bleomycin—melanoma	0.000171	0.00157	CcSEcCtD
Gadopentetate dimeglumine—Hypertension—Docetaxel—melanoma	0.00017	0.00157	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Dactinomycin—melanoma	0.00017	0.00157	CcSEcCtD
Gadopentetate dimeglumine—Rash—Dactinomycin—melanoma	0.000169	0.00155	CcSEcCtD
Gadopentetate dimeglumine—Arthralgia—Docetaxel—melanoma	0.000168	0.00155	CcSEcCtD
Gadopentetate dimeglumine—Chest pain—Docetaxel—melanoma	0.000168	0.00155	CcSEcCtD
Gadopentetate dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.000167	0.00153	CcSEcCtD
Gadopentetate dimeglumine—Dizziness—Carmustine—melanoma	0.000166	0.00152	CcSEcCtD
Gadopentetate dimeglumine—Diarrhoea—Temozolomide—melanoma	0.000166	0.00152	CcSEcCtD
Gadopentetate dimeglumine—Dry mouth—Docetaxel—melanoma	0.000164	0.00151	CcSEcCtD
Gadopentetate dimeglumine—Confusional state—Docetaxel—melanoma	0.000162	0.00149	CcSEcCtD
Gadopentetate dimeglumine—Anaphylactic shock—Docetaxel—melanoma	0.000161	0.00148	CcSEcCtD
Gadopentetate dimeglumine—Dizziness—Temozolomide—melanoma	0.00016	0.00147	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Carmustine—melanoma	0.000159	0.00147	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Dactinomycin—melanoma	0.000159	0.00146	CcSEcCtD
Gadopentetate dimeglumine—Shock—Docetaxel—melanoma	0.000158	0.00146	CcSEcCtD
Gadopentetate dimeglumine—Rash—Carmustine—melanoma	0.000158	0.00145	CcSEcCtD
Gadopentetate dimeglumine—Nervous system disorder—Docetaxel—melanoma	0.000158	0.00145	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Carmustine—melanoma	0.000158	0.00145	CcSEcCtD
Gadopentetate dimeglumine—Tachycardia—Docetaxel—melanoma	0.000157	0.00145	CcSEcCtD
Gadopentetate dimeglumine—Headache—Carmustine—melanoma	0.000157	0.00144	CcSEcCtD
Gadopentetate dimeglumine—Skin disorder—Docetaxel—melanoma	0.000156	0.00144	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Temozolomide—melanoma	0.000154	0.00142	CcSEcCtD
Gadopentetate dimeglumine—Anorexia—Docetaxel—melanoma	0.000154	0.00141	CcSEcCtD
Gadopentetate dimeglumine—Rash—Temozolomide—melanoma	0.000153	0.0014	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Temozolomide—melanoma	0.000153	0.0014	CcSEcCtD
Gadopentetate dimeglumine—Headache—Temozolomide—melanoma	0.000152	0.0014	CcSEcCtD
Gadopentetate dimeglumine—Hypotension—Docetaxel—melanoma	0.000151	0.00138	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Carmustine—melanoma	0.000149	0.00137	CcSEcCtD
Gadopentetate dimeglumine—Musculoskeletal discomfort—Docetaxel—melanoma	0.000147	0.00135	CcSEcCtD
Gadopentetate dimeglumine—Paraesthesia—Docetaxel—melanoma	0.000145	0.00133	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Temozolomide—melanoma	0.000144	0.00132	CcSEcCtD
Gadopentetate dimeglumine—Dyspnoea—Docetaxel—melanoma	0.000144	0.00132	CcSEcCtD
Gadopentetate dimeglumine—Somnolence—Docetaxel—melanoma	0.000143	0.00132	CcSEcCtD
Gadopentetate dimeglumine—Decreased appetite—Docetaxel—melanoma	0.00014	0.00129	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal disorder—Docetaxel—melanoma	0.000139	0.00128	CcSEcCtD
Gadopentetate dimeglumine—Fatigue—Docetaxel—melanoma	0.000139	0.00128	CcSEcCtD
Gadopentetate dimeglumine—Pain—Docetaxel—melanoma	0.000138	0.00127	CcSEcCtD
Gadopentetate dimeglumine—Constipation—Docetaxel—melanoma	0.000138	0.00127	CcSEcCtD
Gadopentetate dimeglumine—Feeling abnormal—Docetaxel—melanoma	0.000133	0.00122	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal pain—Docetaxel—melanoma	0.000132	0.00121	CcSEcCtD
Gadopentetate dimeglumine—Abdominal pain—Docetaxel—melanoma	0.000127	0.00117	CcSEcCtD
Gadopentetate dimeglumine—Body temperature increased—Docetaxel—melanoma	0.000127	0.00117	CcSEcCtD
Gadopentetate dimeglumine—Hypersensitivity—Docetaxel—melanoma	0.000119	0.00109	CcSEcCtD
Gadopentetate dimeglumine—PGD—Carbohydrate metabolism—LUM—melanoma	0.000117	0.0339	CbGpPWpGaD
Gadopentetate dimeglumine—Asthenia—Docetaxel—melanoma	0.000116	0.00106	CcSEcCtD
Gadopentetate dimeglumine—PGD—Carbohydrate metabolism—HPSE—melanoma	0.000115	0.0333	CbGpPWpGaD
Gadopentetate dimeglumine—Pruritus—Docetaxel—melanoma	0.000114	0.00105	CcSEcCtD
Gadopentetate dimeglumine—Diarrhoea—Docetaxel—melanoma	0.00011	0.00101	CcSEcCtD
Gadopentetate dimeglumine—PGD—Carbohydrate metabolism—CSPG4—melanoma	0.000109	0.0315	CbGpPWpGaD
Gadopentetate dimeglumine—Dizziness—Docetaxel—melanoma	0.000107	0.00098	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Docetaxel—melanoma	0.000102	0.000942	CcSEcCtD
Gadopentetate dimeglumine—Rash—Docetaxel—melanoma	0.000102	0.000934	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Docetaxel—melanoma	0.000101	0.000933	CcSEcCtD
Gadopentetate dimeglumine—Headache—Docetaxel—melanoma	0.000101	0.000928	CcSEcCtD
Gadopentetate dimeglumine—PGD—NRF2 pathway—SLC5A5—melanoma	9.75e-05	0.0283	CbGpPWpGaD
Gadopentetate dimeglumine—Nausea—Docetaxel—melanoma	9.57e-05	0.00088	CcSEcCtD
Gadopentetate dimeglumine—PGD—Carbohydrate metabolism—VCAN—melanoma	8.03e-05	0.0233	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—NRF2 pathway—HGF—melanoma	7.21e-05	0.0209	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—MYO7A—melanoma	6.3e-05	0.0183	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Carbohydrate metabolism—CD44—melanoma	5.95e-05	0.0173	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—HS3ST5—melanoma	5.36e-05	0.0156	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—ACER3—melanoma	5.28e-05	0.0153	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—UGT2B10—melanoma	4.83e-05	0.014	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—HS3ST5—melanoma	4.49e-05	0.013	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—CUL3—melanoma	3.82e-05	0.0111	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—TRRAP—melanoma	3.82e-05	0.0111	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—AKR1B10—melanoma	3.71e-05	0.0108	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—PLCB4—melanoma	3.4e-05	0.00987	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—LUM—melanoma	3.31e-05	0.00961	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—HPSE—melanoma	3.25e-05	0.00942	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—PIP4K2A—melanoma	3.2e-05	0.00928	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—SLC6A11—melanoma	3.2e-05	0.00928	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—CUBN—melanoma	3.19e-05	0.00925	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—MTAP—melanoma	3.11e-05	0.00903	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—CSPG4—melanoma	3.08e-05	0.00893	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—RPS3—melanoma	3.03e-05	0.00879	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—SKI—melanoma	2.98e-05	0.00865	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—LUM—melanoma	2.77e-05	0.00805	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—PHGDH—melanoma	2.77e-05	0.00805	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—HPSE—melanoma	2.72e-05	0.00789	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—CUBN—melanoma	2.67e-05	0.00774	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—SDHD—melanoma	2.58e-05	0.00748	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—CSPG4—melanoma	2.58e-05	0.00748	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—BSG—melanoma	2.58e-05	0.00748	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—GPAM—melanoma	2.5e-05	0.00724	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—HDAC6—melanoma	2.46e-05	0.00714	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—NPPA—melanoma	2.33e-05	0.00677	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—VCAN—melanoma	2.28e-05	0.00661	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—WNT5A—melanoma	2.26e-05	0.00656	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—PLA2G6—melanoma	2.12e-05	0.00616	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—neck—melanoma	1.92e-05	0.225	CbGeAlD
Gadopentetate dimeglumine—PGD—Metabolism—VCAN—melanoma	1.91e-05	0.00553	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—GAB2—melanoma	1.81e-05	0.00526	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—FASN—melanoma	1.77e-05	0.00515	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—HDAC2—melanoma	1.71e-05	0.00495	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—FOXO4—melanoma	1.71e-05	0.00495	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—CXCR4—melanoma	1.71e-05	0.00495	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—CD44—melanoma	1.69e-05	0.00489	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—CYP17A1—melanoma	1.61e-05	0.00467	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—AKT3—melanoma	1.56e-05	0.00452	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—GNA11—melanoma	1.52e-05	0.00441	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—FASN—melanoma	1.49e-05	0.00431	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—SLC5A5—melanoma	1.46e-05	0.00424	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—eye—melanoma	1.43e-05	0.168	CbGeAlD
Gadopentetate dimeglumine—PGD—retina—melanoma	1.41e-05	0.166	CbGeAlD
Gadopentetate dimeglumine—PGD—Metabolism—GNAQ—melanoma	1.41e-05	0.0041	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—CD44—melanoma	1.41e-05	0.0041	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—ERBB4—melanoma	1.37e-05	0.00399	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—CDKN2B—melanoma	1.36e-05	0.00395	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—CYP1B1—melanoma	1.35e-05	0.00393	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—CD86—melanoma	1.32e-05	0.00382	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—FGF1—melanoma	1.28e-05	0.00371	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—skin of body—melanoma	1.24e-05	0.146	CbGeAlD
Gadopentetate dimeglumine—PGD—Disease—PDGFRA—melanoma	1.24e-05	0.00359	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—PRKCA—melanoma	1.22e-05	0.00356	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—ERCC2—melanoma	1.21e-05	0.00353	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—MAP2K2—melanoma	1.2e-05	0.00348	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—HLA-A—melanoma	1.14e-05	0.00331	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—TERT—melanoma	1.14e-05	0.00331	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—RAC1—melanoma	1.14e-05	0.0033	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—mammalian vulva—melanoma	1.13e-05	0.133	CbGeAlD
Gadopentetate dimeglumine—PGD—Metabolism—ABCB1—melanoma	1.11e-05	0.00324	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—HIF1A—melanoma	1.09e-05	0.00316	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—PRKCA—melanoma	1.03e-05	0.00298	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—ERCC2—melanoma	1.02e-05	0.00295	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—NOS2—melanoma	9.91e-06	0.00288	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—NOTCH1—melanoma	9.81e-06	0.00285	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—CD80—melanoma	9.61e-06	0.00279	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—APC—melanoma	9.59e-06	0.00279	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—KIT—melanoma	9.59e-06	0.00279	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—EGF—melanoma	9.48e-06	0.00275	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—BRAF—melanoma	9.02e-06	0.00262	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—MAP2K1—melanoma	8.49e-06	0.00246	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—PIK3CD—melanoma	8.43e-06	0.00245	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—head—melanoma	8.1e-06	0.0952	CbGeAlD
Gadopentetate dimeglumine—PGD—Disease—FGF2—melanoma	8.08e-06	0.00234	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—PIK3CG—melanoma	8.04e-06	0.00233	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—PPARG—melanoma	7.76e-06	0.00225	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—MDM2—melanoma	7.56e-06	0.00219	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—ERBB2—melanoma	7.45e-06	0.00216	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—PIK3CB—melanoma	7.35e-06	0.00213	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—CD4—melanoma	7.34e-06	0.00213	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—PTGS2—melanoma	7.28e-06	0.00211	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—PIK3CD—melanoma	7.06e-06	0.00205	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—ALB—melanoma	6.97e-06	0.00202	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—CDKN1B—melanoma	6.9e-06	0.002	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—CTNNB1—melanoma	6.52e-06	0.00189	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—CDKN1A—melanoma	6.37e-06	0.00185	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—PTEN—melanoma	6.35e-06	0.00184	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—PIK3CB—melanoma	6.16e-06	0.00179	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—PTGS2—melanoma	6.1e-06	0.00177	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—STAT3—melanoma	5.68e-06	0.00165	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—lymph node—melanoma	5.67e-06	0.0666	CbGeAlD
Gadopentetate dimeglumine—PGD—Disease—NRAS—melanoma	5.67e-06	0.00165	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—MAPK3—melanoma	5.43e-06	0.00158	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—PTEN—melanoma	5.32e-06	0.00154	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—MYC—melanoma	5.28e-06	0.00153	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—MAPK1—melanoma	5.16e-06	0.0015	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—EGFR—melanoma	5.16e-06	0.0015	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—KRAS—melanoma	4.88e-06	0.00142	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—PIK3CA—melanoma	4.48e-06	0.0013	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—HRAS—melanoma	4.15e-06	0.0012	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—IL6—melanoma	3.97e-06	0.00115	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—PIK3CA—melanoma	3.75e-06	0.00109	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—AKT1—melanoma	3.66e-06	0.00106	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—AKT1—melanoma	3.07e-06	0.00089	CbGpPWpGaD
